Nia Therapeutics
Allston, US · Founded 2016 · Delaware corporation · 18 employees on LinkedIn
Find your way into Nia Therapeutics
147 people in our graph share verified history with the Nia Therapeutics team — schools, employers, funds. One of them is your warm intro.
KT Mooreunlockedknows Michael Kahana · together at Case Western Reserve University (overlapped)
×10knows the team · via Case Western Reserve University
knows the team · via Brandeis University
Founders & leadership
Nia Therapeutics was founded in 2016 by Michael Kahana and Daniel Rizzuto.
MK
Michael KahanainChair of Scientific Advisory Board and Co-FounderMichael Kahana is a neuroscientist whose research focuses on human memory and its neural mechanisms through behavioral, computational, and electrophysiological approaches. He earned his PhD from the University of Toronto in 1993, held postdoctoral positions at Harvard, and became a faculty member at Brandeis University; his work has produced over 230 peer-reviewed publications and includes co-editorship of the Oxford Handbook of Memory and authorship of "Foundations of Human Memory."
DR
Daniel RizzutoCo-founder
DU
Daniel UtinExecutive
Board
JW
Jonathan WachterBoard director
LG
Larry GreenbergBoard director
MM
Milton MorrisBoard director
Reported raises · per SEC filings
Form D private placements$26.1M disclosed across 4 of 7 rounds · 2018–2024
▶$23.6MraisedJun 2026 · 37 investors · Other Health CareRule 506(b)
▶$23.6MraisedJun 2026 · 37 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Michael KahanaExecutive Officer, Director
- Daniel RizzutoExecutive Officer, Director
- Jonathan WachterDirector
- Daniel UtinExecutive Officer
- Larry GreenbergDirector
- Milton MorrisDirector
- Offering amount
- $26.5M
- Amount sold
- $23.6M
- Minimum investment
- $50K
- Proceeds to insiders
- $1.9M
- First sale
- Dec 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1offeredFeb 2024 · Other Health CareRule 506(b)
▶$1offeredFeb 2024 · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Daniel RizzutoExecutive Officer, Director
- Jonathan WachterDirector
- Larry GreenbergDirector
- Daniil UtinExecutive Officer
- Offering amount
- $1
- First sale
- Dec 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.5MraisedSep 2020 · 3 investors · Other Health CareRule 506(b)
▶$1.5MraisedSep 2020 · 3 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Daniel RizzutoExecutive Officer, Director
- Larry GreenbergDirector
- Offering amount
- $2M
- Amount sold
- $1.5M
- First sale
- Jul 2020
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$200KraisedSep 2019 · 1 investors · Other Health CareRule 506(b)
▶$200KraisedSep 2019 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Larry GreenbergDirector
- Daniel RizzutoExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $200K
- First sale
- Sep 2019
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$850KraisedNov 2018 · 3 investors · Other Health CareRule 506(b)
▶$850KraisedNov 2018 · 3 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Daniel RizzutoExecutive Officer, Director
- Michael KahanaExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $850K
- First sale
- Oct 2018
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who founded Nia Therapeutics?
- Nia Therapeutics was founded by Michael Kahana, Daniel Rizzuto in 2016.
- How much funding has Nia Therapeutics raised?
- Nia Therapeutics has disclosed $26.1M raised across 4 of its 7 known rounds.
- Where is Nia Therapeutics headquartered?
- Nia Therapeutics is headquartered in Allston, US.